Cannabidiol enhances the inhibitory effects of Δ(9)-tetrahydrocannabinol on human glioblastoma cell proliferation and survival

The cannabinoid 1 (CB(1)) and cannabinoid 2 (CB(2)) receptor agonist, Δ(9)-tetrahydrocannabinol (THC), has been shown to be a broad range inhibitor of cancer in culture and in vivo, and is currently being used in a clinical trial for the treatment of glioblastoma. It has been suggested that other pl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Marcu, Jahan P., Christian, Rigel T., Lau, Darryl, Zielinski, Anne J., Horowitz, Maxx P., Lee, Jasmine, Pakdel, Arash, Allison, Juanita, Limbad, Chandani, Moore, Dan H., Yount, Garret L., Desprez, Pierre-Yves, McAllister, Sean D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2806496/
https://ncbi.nlm.nih.gov/pubmed/20053780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-09-0407
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados